Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1150 of 1294 entries
View as:

A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02717858 Org: User:
Start: 03/16/16 End: 02/27/17 Due: 02/27/18

Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02392117 Org: User:
Start: 03/16/15 End: 03/19/18 Due: 03/19/19

Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06655493 Org: User:
Start: 12/01/24 End: 09/30/25 Due: 09/30/26

Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

Phase: N/A Priority: Normal
NCT ID: NCT01034202 Org: User:
Start: 08/31/07 End: 01/31/08 Due: 01/31/09

A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea

Phase: N/A Priority: Normal
NCT ID: NCT07018544 Org: User:
Start: 11/19/24 End: 02/28/27 Due: 02/28/28

A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT06370819 Org: User:
Start: 04/15/24 End: 11/27/24 Due: 11/27/25

Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02863328 Org: User:
Start: 08/10/16 End: 03/08/18 Due: 03/08/19

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Phase: N/A Priority: Normal
NCT ID: NCT00675220 Org: User:
Start: 06/30/07 End: 12/31/07 Due: 12/31/08

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing

Phase: N/A Priority: Normal
NCT ID: NCT06820476 Org: User:
Start: 02/09/25 End: 05/14/25 Due: 05/14/26

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

Phase: N/A Priority: Normal
NCT ID: NCT00127296 Org: User:
Start: 07/31/05 End: 09/30/05 Due: 09/30/06

Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00571935 Org: User:
Start: 08/31/03 End: 10/31/04 Due: 10/31/05

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00592969 Org: User:
Start: 12/03/03 End: 11/02/04 Due: 11/02/05

A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates

Phase: N/A Priority: Normal
NCT ID: NCT03823339 Org: User:
Start: 01/29/19 End: 12/14/20 Due: 12/14/21

Comparison of Two Identical NN1250 Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01193387 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00331604 Org: User:
Start: 08/31/06 End: 05/05/08 Due: 05/05/09

Post-marketing Surveillance (Use Result Surveillance) With Refixia®

Phase: N/A Priority: Normal
NCT ID: NCT03875547 Org: User:
Start: 08/23/19 End: 09/30/25 Due: 09/30/26

The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin

Phase: N/A Priority: Normal
NCT ID: NCT01043510 Org: User:
Start: 01/31/10 End: 10/31/10 Due: 10/31/11

A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists

Phase: N/A Priority: Normal
NCT ID: NCT06589791 Org: User:
Start: 09/09/24 End: 12/05/24 Due: 12/05/25

A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia

Phase: N/A Priority: Normal
NCT ID: NCT05479591 Org: User:
Start: 07/30/22 End: 04/30/23 Due: 04/30/24

An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01498900 Org: User:
Start: 08/31/04 End: 07/31/06 Due: 07/31/07

A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01999322 Org: User:
Start: 11/19/13 End: 05/14/14 Due: 05/14/15

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00184626 Org: User:
Start: 09/10/04 End: 10/24/05 Due: 10/24/06

A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04262661 Org: User:
Start: 03/02/20 End: 09/25/20 Due: 09/25/21

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00824668 Org: User:
Start: 08/31/07 End: 10/31/07 Due: 10/31/08

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Phase: N/A Priority: Normal
NCT ID: NCT02906930 Org: User:
Start: 09/20/16 End: 12/08/17 Due: 12/08/18